Compounds > olmesartan
Page last updated: 2024-09-04

olmesartan and Hypertension, Essential

olmesartan has been researched along with Hypertension, Essential in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's12 (63.16)24.3611
2020's7 (36.84)2.80

Authors

AuthorsStudies
Gotou, H; Kario, K; Rakugi, H; Sasajima, T; Yamaguchi, M; Zhang, J1
Abe, T; Bekki, M; Fukumoto, Y; Honda, A; Igata, S; Kurata, S; Maeda-Ogata, S; Matsui, T; Nishino, Y; Sugiyama, Y; Tahara, A; Tahara, N; Yamagishi, SI1
Almarjan, AI; Almarjan, SA; Masoud, AT1
Eguchi, S; Iekushi, K; Kario, K; Morita, Y; Rakugi, H; Yarimizu, D1
Chen, X; Jia, S; Li, X; Liao, H; Liu, K; Liu, X; Meng, Q; Shi, R; Sun, L; Wang, S; Wang, Z; Xu, M; Ye, R; Zhang, X; Zhang, Z1
Chang, K; Chung, WB; Her, SH; Ihm, SH; Jang, SW; Jeon, DS; Lee, JM; Park, CS; Seung, KB; Yoo, KD1
Adachi, S; Fujisawa, K; Hitaka, Y; Ideishi, M; Inoue, A; Inoue, K; Kusumoto, T; Kuwano, T; Miura, SI; Motozato, K; Norimatsu, K; Saku, K; Shiga, Y; Shirotani, T; Yano, M1
Aichner, S; Albrecht, D; Bremerich, J; Delles, C; Freyhardt, P; Heye, T; Hrabak-Paar, M; Janka, R; Keicher, C; Khder, Y; Langenickel, T; Mayr, M; Ott, C; Schmieder, RE; Wagner, F; Yates, D1
Ruilope, LM; Ruiz-Hurtado, G1
Dong, P; Liu, H; Zhao, D1
Guo, W; Huo, Y; Li, W; Wang, Q; Webb, R; Zhao, L1
Bulnes, JF; Cantin, C; Córdova, S; Gabrielli, L; Godoy, I; Jalil, JE; MacNab, P; Novoa, U; Ocaranza, MP1
Bramlage, P; Fimmers, R; Gansz, A; Lüders, S; Nadal, J; Schmieder, RE; Schrader, J; Sturm, CD; Zemmrich, C2
Amaya, N; Arakawa, K; Fukuoka, Y; Ishida, K; Lee, JD; Morishita, T; Nakano, A; Tada, H; Uzui, H1
Bramlage, P; Fronk, EM; Ketelhut, R; Schmieder, RE; Smolnik, R; Wolf, WP; Zemmrich, C1
Colardelle, P; Ould Sidi Mohamed, M1
Pichler, G; Redon, J1
Arimoto, M; Hata, H; Osaka, S; Sakino, H; Sezai, A; Shiono, M; Yaoita, H1

Reviews

2 review(s) available for olmesartan and Hypertension, Essential

ArticleYear
Different Doses of Sacubitril/Valsartan Compared with Olmesartan in Patients with Essential Hypertension: A Systematic Review and Meta-Analysis.
    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2023, Volume: 30, Issue:3

    Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Blood Pressure; Drug Combinations; Essential Hypertension; Humans; Hypertension; Tetrazoles; Valsartan

2023
Antihypertensive effect of azilsartan versus olmesartan in patients with essential hypertension: a meta-analysis.
    Irish journal of medical science, 2019, Volume: 188, Issue:2

    Topics: Antihypertensive Agents; Benzimidazoles; Blood Pressure; Essential Hypertension; Humans; Imidazoles; Oxadiazoles; Tetrazoles

2019

Trials

13 trial(s) available for olmesartan and Hypertension, Essential

ArticleYear
Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2022, Volume: 45, Issue:5

    Topics: Aminobutyrates; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Essential Hypertension; Humans; Hypertension; Imidazoles; Japan; Tetrazoles; Treatment Outcome; Valsartan

2022
Effects of olmesartan and amlodipine on blood pressure, endothelial function, and vascular inflammation.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2023, Volume: 30, Issue:4

    Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Essential Hypertension; Humans; Hypertension; Inflammation; Middle Aged

2023
Twenty-Four-Hour Blood Pressure-Lowering Efficacy of Sacubitril/Valsartan Versus Olmesartan in Japanese Patients With Essential Hypertension Based on Nocturnal Blood Pressure Dipping Status: A Post Hoc Analysis of Data From a Randomized, Double-Blind Mult
    Journal of the American Heart Association, 2023, 04-18, Volume: 12, Issue:8

    Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; East Asian People; Essential Hypertension; Humans; Hypertension; Tetrazoles; Valsartan

2023
The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-
    Trials, 2023, Nov-28, Volume: 24, Issue:1

    Topics: Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; East Asian People; Essential Hypertension; Humans; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic

2023
Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter,
    Drug design, development and therapy, 2020, Volume: 14

    Topics: Adult; Aged; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Double-Blind Method; Essential Hypertension; Female; Humans; Imidazoles; Male; Middle Aged; Pyrimidines; Republic of Korea; Tetrazoles; Valsartan; Young Adult

2020
Comparison of Efficacy and Safety of Azilsartan and Olmesartan in Patients With Essential Hypertension.
    International heart journal, 2017, May-31, Volume: 58, Issue:3

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Blood Pressure; Dose-Response Relationship, Drug; Essential Hypertension; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Male; Oxadiazoles; Prospective Studies; Tetrazoles; Time Factors; Treatment Outcome

2017
The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
    European heart journal, 2017, Nov-21, Volume: 38, Issue:44

    Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Aorta; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Combinations; Essential Hypertension; Female; Heart Failure; Humans; Hypertrophy, Left Ventricular; Imidazoles; Magnetic Resonance Angiography; Male; Medication Adherence; Middle Aged; Neprilysin; Tetrazoles; Valsartan; Vascular Stiffness; Ventricular Remodeling

2017
Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double-blind, 8-week study.
    Journal of clinical hypertension (Greenwich, Conn.), 2019, Volume: 21, Issue:1

    Topics: Aged; Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Asian People; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Combinations; Essential Hypertension; Female; Humans; Imidazoles; Male; Middle Aged; Neprilysin; Safety; Systole; Tetrazoles; Valsartan

2019
Daytime systolic ambulatory blood pressure with a direct switch between candesartan monotherapy and the fixed-dose combination olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-1).
    Journal of clinical hypertension (Greenwich, Conn.), 2013, Volume: 15, Issue:11

    Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Systole; Tetrazoles; Treatment Outcome

2013
Effects of combination therapy with olmesartan and azelnidipine on serum osteoprotegerin in patients with hypertension.
    Journal of cardiovascular pharmacology and therapeutics, 2014, Volume: 19, Issue:3

    Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Azetidinecarboxylic Acid; Biomarkers; Blood Pressure; C-Reactive Protein; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Matrix Metalloproteinase 2; Middle Aged; Osteoprotegerin; Prospective Studies; Tetrazoles

2014
Daytime systolic ambulatory blood pressure with a two-step switch from candesartan to olmesartan monotherapy and the fixed-dose combination of olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-2).
    Journal of clinical hypertension (Greenwich, Conn.), 2014, Volume: 16, Issue:1

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Prospective Studies; Tetrazoles; Treatment Outcome; White People

2014
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
    Journal of hypertension, 2016, Volume: 34, Issue:2

    Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Essential Hypertension; Female; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Perindopril; Tetrazoles; Treatment Outcome

2016
Changeover Trial of Azilsartan and Olmesartan Comparing Effects on the Renin-Angiotensin-Aldosterone System in Patients with Essential Hypertension after Cardiac Surgery (CHAOS Study).
    Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2016, Jun-20, Volume: 22, Issue:3

    Topics: Aged; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Biomarkers; Blood Pressure; Cardiac Surgical Procedures; Drug Substitution; Essential Hypertension; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Imidazoles; Japan; Male; Middle Aged; Oxadiazoles; Prospective Studies; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome; Ventricular Remodeling

2016

Other Studies

4 other study(ies) available for olmesartan and Hypertension, Essential

ArticleYear
Advantages of sacubitril/valsartan beyond blood pressure control in arterial hypertension.
    European heart journal, 2017, 11-21, Volume: 38, Issue:44

    Topics: Aminobutyrates; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Combinations; Essential Hypertension; Humans; Hypertension; Imidazoles; Tetrazoles; Valsartan

2017
Effect of Early Normotension with Olmesartan on Rho-kinase Activity in Hypertensive Patients.
    Current vascular pharmacology, 2020, Volume: 18, Issue:1

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Down-Regulation; Essential Hypertension; Female; Humans; Imidazoles; Leukocytes, Mononuclear; Male; Middle Aged; Myosin-Light-Chain Phosphatase; Phosphorylation; Pilot Projects; Prospective Studies; rho-Associated Kinases; Tetrazoles; Time Factors; Treatment Outcome

2020
Clinical impact of patient adherence to a fixed-dose combination of olmesartan, amlodipine and hydrochlorothiazide.
    Clinical drug investigation, 2014, Volume: 34, Issue:6

    Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Blood Pressure; Drug Combinations; Essential Hypertension; Europe; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Prospective Studies; Risk Factors; Surveys and Questionnaires; Tetrazoles; Young Adult

2014
[Enteropathy due to olmesartan].
    Annales de cardiologie et d'angeiologie, 2016, Volume: 65, Issue:2

    Topics: Antihypertensive Agents; Atrophy; Biopsy; Diarrhea; Duodenitis; Duodenum; Essential Hypertension; Humans; Hypertension; Imidazoles; Male; Middle Aged; Tetrazoles; Withholding Treatment

2016